Two radiologists who used image-guided injection to administer steroids tainted with fungus to at least 30 plaintiffs argue that they would only be liable if the plaintiffs sought to bring medical malpractice lawsuits against them.

Federal multidistrict litigation, pending over the tainted steroid methylprednisolone acetate compounded by the now-shuttered New England Compounding Center, is proceeding in Massachusetts federal court. The now-bankrupt compounding pharmacy produced an injectable steroid that became infected with fungus and led to a fatal breakout of meningitis.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]